Circulating cell-free dna in breast cancer : Searching for hidden information towards precision medicine

Google Scholar: cites

(Democritus University of Thrace(DUTH))
Esteller, M

(Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Chatzaki, Ekaterini

(Democritus University of Thrace(DUTH))

Data:	2021
Resum:	Breast cancer (BC) is a leading cause of death between women. Mortality is significantly raised due to drug resistance and metastasis, while personalized treatment options are obstructed by the limitations of conventional biopsy follow-up. Lately, research is focusing on circulating biomarkers as minimally invasive choices for diagnosis, prognosis and treatment monitoring. Circulating cell-free DNA (ccfDNA) is a promising liquid biopsy biomaterial of great potential as it is thought to mirror the tumor's lifespan; however, its clinical exploitation is burdened mainly by gaps in knowledge of its biology and specific characteristics. The current review aims to gather latest findings about the nature of ccfDNA and its multiple molecular and biological characteristics in breast cancer, covering basic and translational research and giving insights about its validity in a clinical setting.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Breast cancer ; Biomarker ; Circulating cell-free DNA ; Liquid biopsy ; Prognosis ; Monitoring
Publicat a:	Cancers, Vol. 13 Núm. 4 (february 2021) , p. 1-26, ISSN 2072-6694

25 p, 1.2 MB

Registre creat el 2023-01-17, darrera modificació el 2023-06-27